Last verified: March 2026

Chicago: Where Big Cannabis Lives

No city in America has a deeper concentration of cannabis corporate power than Chicago. Cresco Labs, Green Thumb Industries (GTI), and Verano Holdings — three of the five largest multi-state operators (MSOs) in the country — are all headquartered here. PharmaCann, a significant private operator, is also based in the Chicago area. Together, these companies operate hundreds of dispensaries across dozens of states, employ thousands of people, and generate billions in annual revenue.

This is not an accident. It is a direct consequence of Illinois's 2013 medical cannabis licensing decisions, which created a small group of well-capitalized incumbents years before recreational legalization — and years before social equity was part of the conversation.

The Big Three

Cresco Labs

CEO: Charlie Bachtell. Retail brand: Sunnyside. Q4 2025 revenue: $162 million. 2024 operating cash flow: $132 million.

Cresco is the largest cannabis wholesaler in the United States. Its Sunnyside dispensaries are among the highest-traffic in Chicago, including the flagship River North location (436 N. Clark) and the Wrigleyville store (3524 N. Clark) that sits 400 feet from Wrigley Field with 21 point-of-sale terminals. Cresco's flower brands — including the LA Kush Cake that costs twice as much at its own Chicago stores as it does in Michigan — are among the most recognized in Illinois.

Green Thumb Industries (GTI)

Founder/CEO: Ben Kovler (founded 2014). Retail brand: RISE. Q2 2025 revenue: $293 million. Scale: 108 RISE dispensaries across 14 states, approximately 4,900 employees.

GTI is widely considered the most profitable public cannabis company in America. Its brand portfolio — RYTHM (flower), Dogwalkers (pre-rolls), incredibles (edibles), and Beboe (luxury) — spans every product category. GTI's partnership with The Salt Shed, Chicago's premier live music venue on the North Branch of the Chicago River, represents one of the most visible cannabis-entertainment integrations in the country.

Verano Holdings

Founder/CEO: George Archos. Retail brand: Zen Leaf. Scale: 96+ Zen Leaf dispensaries across 15 states.

Verano operates multiple Zen Leaf locations in Chicago, including the West Loop (222 S. Halsted), Rogers Park, and Pilsen stores. The company has been embroiled in an $860 million lawsuit from Vireo Growth related to a failed acquisition agreement, which has cast a shadow over its financial outlook.

PharmaCann

Status: Private. Retail brand: Verilife.

Unlike the publicly traded Big Three, PharmaCann operates privately through its Verilife dispensary chain. Its Rosemont location near O'Hare Airport is one of the most convenient options for visitors flying into Chicago.

The 77% Problem

The dominance of these companies is not just about revenue — it is about structural control of the supply chain. By 2020, six companies controlled 77% of all cannabis cultivation capacity in Illinois. All six held licenses from the 2013 medical program, which was awarded before recreational legalization and before social equity provisions existed.

This concentration created a fundamental tension that defines Chicago's cannabis story:

• The companies that dominate Illinois cannabis were built on medical licenses issued before equity was even discussed
• The Cannabis Business Association of Illinois, representing these incumbents, lobbied against expanding craft grow canopy limits that would have allowed smaller competitors to scale
• Craft growers are capped at 5,000 square feet — compared to the tens of thousands of square feet operated by MSO cultivation facilities
• Of 88 craft grow licenses issued, only 13 are operational as of 2026

MSO Impact on Chicago

The concentration of cannabis corporate headquarters in Chicago has real effects on the city beyond dispensary ownership:

• Jobs: GTI alone employs ~4,900 people. Combined, the Chicago-based MSOs employ tens of thousands nationally, with significant corporate staff in the city.
• Real estate: Cannabis companies occupy premium office space in River North, West Loop, and the Loop.
• Tax revenue: Illinois generated $490 million in cannabis tax revenue in 2024, second nationally behind California.
• Political influence: MSO lobbying shaped the CRTA and continues to influence ongoing regulatory decisions, including license caps, canopy limits, and delivery policy.
• Cultural presence: GTI's Salt Shed partnership, Cresco's Wrigleyville location, and Verano's neighborhood dispensaries make cannabis a visible part of Chicago's commercial landscape.

The Equity Tension

Chicago's identity as the MSO capital exists in direct tension with its identity as the home of the most ambitious equity framework in American cannabis. The same city that houses Cresco's headquarters is the city where 97% of 2018 cannabis arrests targeted Black or Hispanic residents. The same legislature that created the CRTA's equity provisions had already given the incumbents a multi-year head start.

A Nerevu study costing $2.5 million found that white men remain the most likely license holders in Illinois, and three-quarters of cultivation capacity is controlled by white males. The first social equity dispensary did not open until November 2022 — nearly three years after legalization.

For the full equity story, see The Equity Experiment.